Phosphoric acid mono-[5-(3-carbamoyl-[1,2,4]triazol-1-yl)-3,4-dihydroxy-tetrahydro-furan-2-ylmethyl] ester

ID: ALA1235764

Cas Number: 40925-28-8

PubChem CID: 100252

Max Phase: Preclinical

Molecular Formula: C8H13N4O8P

Molecular Weight: 324.19

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Synonyms: NSC-274937 | Ribavirin monophosphate|Ribavirin-5'-phosphate|Virazole 5'-phosphate|40925-28-8|Ribavirin 5'-monophosphate|ICN 3847|Ribavirin 5'-phosphate|O9FVV27P11|1-(5-O-Phosphono-beta-D-ribofuranosyl)-1H-1,2,4-triazole-3-carboxamide|NSC-274937|1beta-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide-5'-phosphate|1H-1,2,4-Triazole-3-carboxamide, 1-(5-O-phosphono-.beta.-D-ribofuranosyl)-|RVP|UNII-O9FVV27P11|Ribavirin-5'-monophosphate|ribavirin-MP|NSC274937|Ribavirin 5'-P|NSC 274937|1me7|1me8|RBV-MP|CHEShow More

Canonical SMILES:  NC(=O)c1ncn([C@@H]2O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]2O)n1

Standard InChI:  InChI=1S/C8H13N4O8P/c9-6(15)7-10-2-12(11-7)8-5(14)4(13)3(20-8)1-19-21(16,17)18/h2-5,8,13-14H,1H2,(H2,9,15)(H2,16,17,18)/t3-,4-,5-,8-/m1/s1

Standard InChI Key:  SDWIOXKHTFOULX-AFCXAGJDSA-N

Molfile:  

     RDKit          2D

 21 22  0  0  0  0  0  0  0  0999 V2000
    8.4540  -11.9091    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.8087  -12.4106    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6966  -11.4532    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2368  -12.1349    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.1836  -10.8065    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.5487  -13.1906    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1525  -11.9277    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.4218  -11.0956    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7315  -13.1865    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4839  -12.4064    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5114  -11.4194    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8918  -10.6962    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.0275  -13.8551    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.9494  -12.1115    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.2486  -13.8427    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.7811  -11.9821    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8048  -11.1617    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.1091  -10.7329    0.0000 P   0  0  0  0  0  0  0  0  0  0  0  0
    5.1327   -9.9160    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.3130  -10.9413    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.1013  -11.5480    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  1
  3  4  2  0
  4  1  1  0
  5  8  2  0
  6  2  1  0
  7  2  1  0
  8  1  1  0
  9  6  1  0
 10  7  1  0
 11  3  1  0
 12 11  2  0
  6 13  1  6
 14 11  1  0
  9 15  1  6
 10 16  1  1
 17 16  1  0
  3  5  1  0
 10  9  1  0
 17 18  1  0
 18 19  2  0
 18 20  1  0
 18 21  1  0
M  END

Associated Targets(Human)

GATA4 Tbio Transcription factor GATA-4 (19 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TBX5 Tbio T-box transcription factor TBX5 (4 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NFATC1 Tchem Nuclear factor of activated T-cells cytoplasmic 1 (86 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HeLa (62764 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HEK293 (82097 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ATIC Tchem AICAR transformylase (241 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

P388 (20296 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
C2C12 (756 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Gata4 Transcription factor GATA-4 (136 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 324.19Molecular Weight (Monoisotopic): 324.0471AlogP: -2.89#Rotatable Bonds: 5
Polar Surface Area: 190.25Molecular Species: ACIDHBA: 9HBD: 5
#RO5 Violations: HBA (Lipinski): 12HBD (Lipinski): 6#RO5 Violations (Lipinski): 2
CX Acidic pKa: 1.22CX Basic pKa: CX LogP: -2.92CX LogD: -6.37
Aromatic Rings: 1Heavy Atoms: 21QED Weighted: 0.35Np Likeness Score: 0.79

References

1. Gebeyehu G, Marquez VE, Van Cott A, Cooney DA, Kelley JA, Jayaram HN, Ahluwalia GS, Dion RL, Wilson YA, Johns DG..  (1985)  Ribavirin, tiazofurin, and selenazofurin: mononucleotides and nicotinamide adenine dinucleotide analogues. Synthesis, structure, and interactions with IMP dehydrogenase.,  28  (1): [PMID:2856943] [10.1021/jm00379a018]
2. El-Hachem N, Nemer G..  (2011)  Identification of new GATA4-small molecule inhibitors by structure-based virtual screening.,  19  (5): [PMID:21310620] [10.1016/j.bmc.2011.01.022]
3. Drabikowska AK, Dudycz L, Shugar D..  (1979)  Studies on the mechanism of antiviral action of 1-(beta-D-ribofuranosyl)-1,2,4-triazole-3-carboxamide (ribavirin).,  22  (6): [PMID:222909] [10.1021/jm00192a009]
4. Cook PD, Allen LB, Streeter DG, Huffman JH, Sidwell RW, Robins RK..  (1978)  Synthesis and antiviral and enzymatic studies of certain 3-deazaguanines and their imidazolecarboxamide precursors.,  21  (12): [PMID:722730] [10.1021/jm00210a008]

Source